Fda

Edit

FDA Approves Cancer Drugs for Head and Neck, Pancreatic Cancers

Chosun Ilbo 12 Nov 2026

Food and Drug Administration (FDA) announced on November 5 that it granted accelerated approval to Johnson & Johnson (J&J)’s cancer drug ‘Rybrevant Paspro’ as a treatment for head and neck cancer.

Edit

HanAll BioPharma's Imeroprubart Succeeds in Phase 2b, Faces FDA Hurdles

Chosun Ilbo 12 Nov 2026

However, many challenges remain ... Its U.S ... It was conducted in two phases ... ◇“Consulting FDA on approval path”…other indications also variables ... Food and Drug Administration (FDA) and subsequent trial plans by early next year at the latest ... .

Edit

Taking Ozempic or Zepbound? FDA orders warning about rare vision loss risk

Hastings Tribune 11 Nov 2026

The Food and Drug Administration is requiring new warnings on GLP-1 drugs, including Ozempic, Wegovy and Zepbound, about a potential increased risk of a rare eye condition that can cause permanent vision loss ... .

Edit

FDA approves new stroke drug after 26% drop in recurrent events

Ynet 11 Nov 2026

Bayer’s once-daily Sunharbo becomes the ...

Edit

GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says

CBS News 11 Nov 2026

GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News to discuss ... .

Edit

FDA plays important role in protecting public

The Galveston Daily News 11 Nov 2026

Everyday biochemists ....

Edit

FDA adds rare vision-loss warning to popular GLP-1 drugs

The Sun Chronicle 11 Nov 2026

WASHINGTON — Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday ... .

Edit

Bayer wins US FDA approval for Sunharbo to reduce repeat strokes

Emirates 24/7 11 Nov 2026

⁠Current big-selling blood-clot preventers, such as Pfizer and Bristol Myers Squibb's Eliquis and Xarelto, sold by Johnson & Johnson and Bayer, work by blocking Factor Xa, a different protein involved in the formation of blood clots ... .

Edit

Ozempic, Wegovy & Mounjaro: US FDA mandates safety warning for eye condition

Indian Express 11 Nov 2026

The warning comes over ...

Edit

FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning

Business Line 11 Nov 2026

... damage is permanent, FDA said ....

Edit

Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral ...

Morgan Citizen 11 Nov 2026

- ASC30_39 FDC, a once-daily oral fixed-dose ...

Edit

2,450 kg chicken destroyed: FDA finds food safety violations, including 700 kg meat brought from Delhi in

The Times of India 11 Nov 2026

.

Edit

NeOnc Technologies Granted FDA Type B End-of-Phase Meeting to Discuss Potential Accelerated Approval Pathway and ...

The Daily Record - Dunn 11 Nov 2026

CALABASAS, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq. NTHI) (“NeOnc” or the ....

Edit

AI4Eyes Completes FDA Registration and Listing for its Eye Care Platform, Opening the Path to ...

The Philadelphia Tribune 11 Nov 2026

Montréal medtech company lists its platform as a Class I, 510(k)-exempt medical device ....

Edit

FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic

Business Line 11 Nov 2026

Indian endocrinologists, ...

Podcasts:

Latest News for: fda

FDA Approves Cancer Drugs for Head and Neck, Pancreatic Cancers

HanAll BioPharma's Imeroprubart Succeeds in Phase 2b, Faces FDA Hurdles

Taking Ozempic or Zepbound? FDA orders warning about rare vision loss risk

FDA approves new stroke drug after 26% drop in recurrent events

GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says

FDA plays important role in protecting public

FDA adds rare vision-loss warning to popular GLP-1 drugs

Bayer wins US FDA approval for Sunharbo to reduce repeat strokes

Ozempic, Wegovy & Mounjaro: US FDA mandates safety warning for eye condition

FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning

Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral ...

2,450 kg chicken destroyed: FDA finds food safety violations, including 700 kg meat brought from Delhi in

NeOnc Technologies Granted FDA Type B End-of-Phase Meeting to Discuss Potential Accelerated Approval Pathway and ...

AI4Eyes Completes FDA Registration and Listing for its Eye Care Platform, Opening the Path to ...

FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic

Article Search

EXPLORE WN.com